Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Gebruik en effectiviteit van antiretrovirale 2DR’s versus 3DR’s
feb 2020 | HIV, Ouderen